Chiron Investment Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-16,121
| Closed | -$8.38M | – | 97 |
|
|
2024
Q3 | $8.38M | Sell |
16,121
-6,255
| -28% | -$3.25M | 2.95% | 9 |
|
|
2024
Q2 | $12.1M | Sell |
22,376
-7,017
| -24% | -$3.8M | 4.76% | 4 |
|
|
2024
Q1 | $15.2M | Sell |
29,393
-11,176
| -28% | -$5.8M | 6.61% | 1 |
|
|
2023
Q4 | $19.1M | Buy |
40,569
+587
| +1% | +$277K | 7.29% | 2 |
|
|
2023
Q3 | $17.4M | Buy |
39,982
+13,817
| +53% | +$6.02M | 7.35% | 2 |
|
|
2023
Q2 | $11.6M | Buy |
+26,165
| New | +$11.6M | 3.26% | 10 |
|
|
2023
Q1 | – | Sell |
-22,787
| Closed | -$11.7M | – | 144 |
|
|
2022
Q4 | $11.7M | Buy |
22,787
+10,894
| +92% | +$5.59M | 2.74% | 15 |
|
|
2022
Q3 | $5.4M | Buy |
+11,893
| New | +$5.4M | 1.09% | 32 |
|
|
2022
Q2 | – | Sell |
-46,273
| Closed | -$22.7M | – | 121 |
|
|
2022
Q1 | $22.7M | Buy |
46,273
+25,944
| +128% | +$12.7M | 2.61% | 18 |
|
|
2021
Q4 | $9.42M | Buy |
+20,329
| New | +$9.42M | 1.03% | 34 |
|